ascendis pharma glp-1 receptor agonists weight management diabetes treatments Schematic illustration of monoagonists, dual and triple Endocrinology Newsmakers: Drugmakers work on
Description
HR Takeaway GLP-1 medications are no longer just a clinical issue, they are a benefits, wellness, and workforce health issue
a , Change in body weight
doi: 10.1016/j.peptides.2017.11.013
T.de LoredoL.TorneK.et al (2015)
While GLP-1 (7-36amide) and GLP-1 (737) are equally potent to stimulate the secretion of insulin and c-peptide [181], GLP-1 (137) has a much lower insulinotropic efficacy [[80], [81], [82]]
La jugabilidad, la navegacin intuitiva y la optimizacin para distintos tamaos de pantalla permiten que la experiencia sea fluida
